Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation
Open Access
- 7 June 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 34 (9), 1955-1967
- https://doi.org/10.1093/carcin/bgt212
Abstract
Remarkable progress in the field of epigenetics has turned academic, medical and public attention to the potential applications of these new advances in medicine and various fields of biomedical research. The result is a broader appreciation of epigenetic phenomena in the a etiology of common human diseases, most notably cancer. These advances also represent an exciting opportunity to incorporate epigenetics and epigenomics into carcinogen identification and safety assessment. Current epigenetic studies, including major international sequencing projects, are expected to generate information for establishing the ‘normal’ epigenome of tissues and cell types as well as the physiological variability of the epigenome against which carcinogen exposure can be assessed. Recently, epigenetic events have emerged as key mechanisms in cancer development, and while our search of the Monograph Volume 100 revealed that epigenetics have played a modest role in evaluating human carcinogens by the International Agency for Research on Cancer (IARC) Monographs so far, epigenetic data might play a pivotal role in the future. Here, we review (i) the current status of incorporation of epigenetics in carcinogen evaluation in the IARC Monographs Programme, (ii) potential modes of action for epigenetic carcinogens, (iii) current in vivo and in vitro technologies to detect epigenetic carcinogens, (iv) genomic regions and epigenetic modifications and their biological consequences and (v) critical technological and biological issues in assessment of epigenetic carcinogens. We also discuss the issues related to opportunities and challenges in the application of epigenetic testing in carcinogen identification and evaluation. Although the application of epigenetic assays in carcinogen evaluation is still in its infancy, important data are being generated and valuable scientific resources are being established that should catalyse future applications of epigenetic testing.Keywords
This publication has 252 references indexed in Scilit:
- Zinc Deprivation Mediates Alcohol-Induced Hepatocyte IL-8 Analog Expression in Rodents via an Epigenetic MechanismThe American Journal of Pathology, 2011
- Radiation-Induced Micro-RNA Expression Changes in Peripheral Blood Cells of Radiotherapy PatientsInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsInternational Journal of Cancer, 2010
- Alu and Satα hypomethylation in Helicobacter pylori‐infected gastric mucosaeInternational Journal of Cancer, 2010
- MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cellsCancer Letters, 2010
- Cigarette smoke induces promoter methylation of single‐stranded DNA‐binding protein 2 in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2010
- Ethanol disrupts chondrification of the neurocranial cartilages in medaka embryos without affecting aldehyde dehydrogenase 1A2 (Aldh1A2) promoter methylationComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2009
- Modulation of histone methylation and MLH1 gene silencing by hexavalent chromiumToxicology and Applied Pharmacology, 2009
- Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell linesBiochemical and Biophysical Research Communications, 2008
- Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology, 2007